These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [MPPG complex belongs in the first phase of drug-assisted lipid lowering (magnesium-pyridoxal-phosphate-glutamate )]. Wieland H Fortschr Med; 1990; 108 Spec No 1():52-3. PubMed ID: 2245961 [No Abstract] [Full Text] [Related]
3. [Effect of hypolipemic drugs on the level of serum lipids in workers and clerks]. Zulić I; Stanković D; Mulabegovic N; Valjevac K; Serdarević D Med Arh; 1978; 32(1):3-6. PubMed ID: 713612 [No Abstract] [Full Text] [Related]
9. [Treatment of hyperlipemia with a new lipid decreasing drug (Ciba 13,437-Su)]. Hede S; Ditzel J; Dyerberg J Nord Med; 1970 Nov; 84(48):1539. PubMed ID: 5486044 [No Abstract] [Full Text] [Related]
10. [Should lipid-lowering drugs be administered to normolipemic or mild hyperlipemic patients with coronary risk factors? Arguments for]. de Teresa Galván E; Jiménez Navarro M Rev Esp Cardiol; 1996 Jul; 49(7):483-5. PubMed ID: 8754441 [No Abstract] [Full Text] [Related]
11. Lipid-lowering drugs and changes to diet can make a difference. TreatmentUpdate; 2001 Aug; 13(4):7-9. PubMed ID: 11590981 [No Abstract] [Full Text] [Related]
13. [Cost-benefit analysis of the therapy of lipid metabolism disorders]. Karádi I Orv Hetil; 1996 May; 137(21):1164. PubMed ID: 8757110 [No Abstract] [Full Text] [Related]
14. [Should lipid-lowering drugs be administered to normolipemic or mild hyperlipemic patients with coronary risk factors? Arguments against]. Brotons Cuixart C; Maiques Galán A Rev Esp Cardiol; 1996 Jul; 49(7):486-91. PubMed ID: 8754442 [No Abstract] [Full Text] [Related]
15. Serum lipids, lipid-lowering drugs, and the risk of breast cancer. Eliassen AH; Colditz GA; Rosner B; Willett WC; Hankinson SE Arch Intern Med; 2005 Oct; 165(19):2264-71. PubMed ID: 16246993 [TBL] [Abstract][Full Text] [Related]
16. The effect of pirozadil on plasma lipids and lipoproteins in 1185 hyperlipidaemic subjects. Multicentre study in general practice in Spain. Tapounet R; Marti Ragué I Drugs Exp Clin Res; 1987; 13(7):447-50. PubMed ID: 3652931 [TBL] [Abstract][Full Text] [Related]
18. Improvement in current approaches to lipid lowering. Ansell BJ Am Fam Physician; 2002 Mar; 65(5):783, 786-7. PubMed ID: 11898952 [No Abstract] [Full Text] [Related]
19. Lipid lowering effects of statins and fibrates in the management of HIV dyslipidemias associated with antiretroviral therapy in HIV clinical practice. Visnegarwala F; Maldonado M; Sajja P; Minihan JL; Rodriguez-Barradas MC; Ong O; Lahart CJ; Hasan MQ; Balasubramanyam A; White AC J Infect; 2004 Nov; 49(4):283-90. PubMed ID: 15474625 [TBL] [Abstract][Full Text] [Related]
20. A vote of no confidence in the precision of the estimated cost-effectiveness of lipid lowering. Wilcock M Br J Gen Pract; 2000 Nov; 50(460):917-8. PubMed ID: 11141882 [No Abstract] [Full Text] [Related] [Next] [New Search]